Elliot Gershon to Biomarkers
This is a "connection" page, showing publications Elliot Gershon has written about Biomarkers.
Connection Strength
0.372
-
Evidence from comprehensive independent validation studies for smooth pursuit dysfunction as a sensorimotor biomarker for psychosis. Sci Rep. 2024 06 15; 14(1):13859.
Score: 0.147
-
Supersensitivity to melatonin suppression by light in young people at high risk for affective disorder. A preliminary report. Neuropsychopharmacology. 1988 Sep; 1(3):217-23.
Score: 0.049
-
Categorical and Dimensional Approaches for Psychiatric Classification and Treatment Targeting: Considerations from Psychosis Biotypes. Adv Neurobiol. 2024; 40:685-723.
Score: 0.036
-
Psychosis Biotypes: Replication and Validation from the B-SNIP Consortium. Schizophr Bull. 2022 01 21; 48(1):56-68.
Score: 0.031
-
Biomarker Profiles in Psychosis Risk Groups Within Unaffected Relatives Based on Familiality and Age. Schizophr Bull. 2021 07 08; 47(4):1058-1067.
Score: 0.030
-
Smooth pursuit eye movement deficits as a biomarker for psychotic features in bipolar disorder-Findings from the PARDIP study. Bipolar Disord. 2020 09; 22(6):602-611.
Score: 0.027
-
Characterizing functional regional homogeneity (ReHo) as a B-SNIP psychosis biomarker using traditional and machine learning approaches. Schizophr Res. 2020 01; 215:430-438.
Score: 0.026
-
Auditory steady-state EEG response across the schizo-bipolar spectrum. Schizophr Res. 2019 07; 209:218-226.
Score: 0.026